PUBLICATIONS

 

9) Mbiki, S., McClendon, J., Alexander-Bryant, A., & Gilmore, J. (2020). Classifying changes in LN-18 glial cell morphology: a supervised machine learning approach to analyzing cell microscopy data via FIJI and WEKA. Medical & biological engineering & computing, 58(7), 1419–1430.

 

8) Iqbal, S., Blenner, M., Alexander-Bryant, A., & Larsen, J. (2020). Polymersomes for Therapeutic Delivery of Protein and Nucleic Acid Macromolecules: From Design to Therapeutic Applications. Biomacromolecules, 21(4), 1327–1350.

 

7) Caffery, B., Lee, J. S., & Alexander-Bryant, A. A. (2019). Vectors for Glioblastoma Gene Therapy: Viral & Non-Viral Delivery Strategies. Nanomaterials (Basel, Switzerland), 9(1), 105.

 

6) Alexander-Bryant, A, Zhang, H, Attaway, C, Pugh, W, Eggart, L, Sansevere, R, Andino, L, Dinh, Lu, Cantini, L, Jakymiw, A, 2017. Dual peptide-mediated targeted delivery of bioactive siRNAs to oral cancer cells in vivo. Oral Oncology, 72: 123-131.

 

5) Alexander-Bryant, A, Hourigan, B, Lynn, M, Lee, JS, “Nanotherapeutics for combination drug and gene therapy in treating glioblastoma multiforme,” Proceedings: AACR 108th Annual Meeting 2017, American Association for Cancer Research, Washington, DC (April 2017).

 

4) Alexander-Bryant, A, Zhang, H, Pugh, W, Dinh, Lu, Attaway, C, Laurence, E, Sansevere, R, Jakymiw, A. “Dual peptide-mediated targeted delivery of siRNAs for the treatment of oral cancer,” Proceedings: AACR 107th Annual Meeting 2016, American Association for Cancer Research, New Orleans, LA (April 2016).

 

3) Alexander-Bryant, A, Dumitriu, A, Attaway, C, Yu, H, Jakymiw, A, 2015. Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo. Journal of Controlled Release, 218: 72-81.

 

2) Alexander-Bryant, A, Dumitriu, A, Attaway, C, Yu, H, Jakymiw, A. “Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo,” Proceedings: AACR 106th Annual Meeting 2015, American Association for Cancer Research, Philadelphia, PA (April 2015).

 

1) Alexander-Bryant, A.A., Vanden Berg-Foels, W.S., Wen, X, 2013. Bioengineering strategies for designing targeted cancer therapies. Advances in Cancer Research 118, 1-59.

 

 

PRESENTATIONS

 

16) Gregory, A, Miller, E, Alexander-Bryant, A, “Implantable peptide-hydrogel drug delivery system for treating glioblastoma multiforme,” SC EPSCoR/IDeA State Conference, Columbia, SC (April 2018).

 

15) Beitz, A., Martin, C., Scammon, B., Nguyen, H., Tatem, L., Dorsey, R., Kelly, J, Alexander-Bryant, A, “Advancing Computed Tomography Imaging in the Brain through Nanoparticle Contrast Agents,” Society for Biomaterials Annual Meeting, Atlanta, GA (April 2018).

 

14) Gregory, A, Miller, E, Alexander-Bryant, A, “Implantable peptide-hydrogel drug delivery system for treating glioblastoma multiforme,” Society for Biomaterials Annual Meeting, Atlanta, GA (April 2018).

 

13) Beitz, A., Martin, C., Scammon, B., Nguyen, H., Tatem, L., Dorsey, R., Kelly, J, Alexander-Bryant, A, “Advancing Computed Tomography Imaging in the Brain through Nanoparticle Contrast Agents,” American Institute of Chemical Engineers (AIChE) 2018 Southern Student Regional Conference, Baton Rouge, LA (April 2018).

 

12) Alexander-Bryant, A, Hourigan, B, Lynn, M, Lee, JS, “Amphiphilic Micelle-Mediated Silencing of MGMT in Glioblastoma Multiforme Tumor Cells In Vivo,” Society for Biomaterials Annual Meeting, Atlanta, GA (April 2018).

 

11) Mbiki, Sarah, Alexander-Bryant, A, McClendon, Jerome, Gilmore, Jordon, “Comparing Machine Learning Algorithms for Real-time Continuous Image Processing of Live Cell Cultures," Biomedical Engineering Society Annual Meeting, Phoenix, AZ (October 2017).

 

10) Alexander-Bryant, A, Hourigan, B, Lynn, M, Lee, JS, “Nanotherapeutics for combination drug and gene therapy in treating glioblastoma multiforme,” Society for Biomaterials Annual Meeting, Minneapolis, MN (April 2017).

 

9) Alexander-Bryant, A, Lynn, M, Lee, JS, “Nanotherapeutics for combination drug and gene therapy in treating glioblastoma multiforme,” Biomedical Engineering Society Annual Meeting, Minneapolis, MN (October 2016).

 

8) Alexander-Bryant, A, Zhang, H, Pugh, W, Dinh, Lu, Attaway, C, Laurence, E, Sansevere, R, Jakymiw, A, “Dual peptide-mediated targeted delivery of siRNAs for the treatment of oral cancer,” Biomedical Engineering Society Annual Meeting, Minneapolis, MN (October 2016).

 

7) Alexander-Bryant, A, Zhang, H, Cantini L, Sansevere R, Dumitriu, A, Jakymiw, A, “Dual peptide-mediated targeted-delivery of siRNAs into oral cancer cells,” James B. Edwards College of Dental Medicine 5th Annual Scholars Day, MUSC, Charleston, SC (February 2015).

 

6) Alexander-Bryant, A, Zhang, H, Cantini L, Sansevere R, Dumitriu, A, Jakymiw, A, “Dual peptide-mediated targeted-delivery of siRNAs into oral cancer cells,” Perry V. Halushka 2014 Student Research Day, MUSC, Charleston, SC (November 2014).

 

5) Alexander-Bryant, A, Zhang, H, Cantini L, Sansevere R, Dumitriu, A, Jakymiw, A, “Dual peptide-mediated targeted-delivery of siRNAs into oral cancer cells,” Southeastern Bioengineering Career Conference, Atlanta, GA (October 2014).

 

4) Alexander-Bryant, A, Alexis, F, Jakymiw, A, “Multigenerational dendrimer delivery of therapeutic siRNAs for enhanced gene silencing in oral cancer cells,” James B. Edwards College of Dental Medicine 4th Annual Scholars Day, MUSC, Charleston, SC (February 2014).

 

3) Alexander-Bryant, A, Alexis, F, Jakymiw, A, “Multigenerational dendrimer delivery of therapeutic siRNAs for enhanced gene silencing in oral cancer cells,” Hollings Cancer Center 13th Annual Research Retreat, Daniel Island, SC (November 2013).

 

2) Alexander, Angela A. and Wen, Xuejun, “Antimicrobial Allylamine-grafted Fibers for Treatment of Wound Infections,” 9th World Biomaterials Congress, Chengdu, China (June 2012).

 

1) Alexander, Angela A. and Wen, Xuejun, “Improving Treatment of Bacterial Infection in Deep Wounds,” Perry V. Halushka 2011 Student Research Day, MUSC, Charleston, SC (November 2011).